Mind Medicine (mindmed) Inc.

Biotechnology • Healthcare • New York, NY, United States • MNMD (NMS)

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.

212 220 6633 One World Trade Center, New York, NY 10007, United States

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Assessing Mind Medicine (MNMD)’s Valuation After Strong Multi‑Year Share Price Gains - Yahoo Finance

Yahoo Finance • Dec 19

Mind Medicine (MindMed) (NASDAQ:MNMD) Sets New 52-Week High - Still a Buy? - MarketBeat

MarketBeat • Jan 5

MindMed Announces New Employee Inducement Grant - Business Wire

Business Wire • Dec 15

Assessing Mind Medicine (MNMD)’s Valuation After a Strong Recent Share Price Rally - simplywall.st

simplywall.st • Dec 19

Mind Medicine (MNMD) Projected to Shine in 2026 with Promising D - GuruFocus

GuruFocus • Jan 5

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Mind Medicine (MindMed) Inc. had layoffs?

No layoff events have been recorded for Mind Medicine (MindMed) Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Mind Medicine (MindMed) Inc. have?

Mind Medicine (MindMed) Inc. has approximately 74 employees.

What industry is Mind Medicine (MindMed) Inc. in?

Mind Medicine (MindMed) Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Mind Medicine (MindMed) Inc. a publicly traded company?

Yes, Mind Medicine (MindMed) Inc. is publicly traded under the ticker symbol MNMD on the NMS. The company has a market capitalization of approximately $1.27 billion.

Where is Mind Medicine (MindMed) Inc. headquartered?

Mind Medicine (MindMed) Inc. is headquartered in New York, NY, United States at One World Trade Center, New York, NY 10007, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.